Biotech IT services in San Diego that protect the science and keep the lab running.

Why lab IT is different from office IT

San Diego County's life sciences cluster is concentrated around Torrey Pines, Sorrento Valley and UTC, with more companies in Carlsbad and the rest of North County. Many start with a handful of people in shared incubator lab space, running on whatever tools the founders already had. A financing round or partnership then adds headcount, a dedicated lab and outside collaborators, often within a few quarters.

• Instruments are computers you can't fully manage. Sequencers, mass spectrometers, plate readers and imaging systems ship with a control PC whose operating system and software are fixed by the vendor or by your own validation. Updating them can void vendor support or trigger revalidation.
• Data is large and has to stay original. Imaging and sequencing runs produce very large files that must move from the instrument to shared storage and analysis without being altered, lost or stranded on one PC.
• The science is the asset. Pre-patent results, assay methods, compound structures and know-how drive valuation, and they are exactly what a careless share link, a departing employee or an attacker would take.
• Many outside hands. Contract research organizations (CROs), academic collaborators, consultants and instrument service engineers all need some access, usually on short notice and for a limited time.
• Facilities share the network. Freezer and incubator alarms, environmental sensors, badge readers and building systems often sit on the same network as staff laptops, with default settings nobody has reviewed.

None of this fits a standard office IT playbook. Strong biotech IT services in San Diego start at the bench and work outward, so the lab keeps running while the rest of the company meets an enterprise standard.

What regulators, partners and investors expect from your IT

No single law dictates how a biotech runs its IT. Expectations arrive from three directions: rules for regulated research if your data will support a submission, security questionnaires from partners and investors, and general privacy and breach laws. Knowing which apply to you keeps the effort where it counts.

Data integrity in regulated research

If your records support FDA submissions or GxP work (the good laboratory, manufacturing and clinical practice regulations), FDA's rules for electronic records and signatures in 21 CFR Part 11 and its data integrity guidance come into play. Regulators describe trustworthy data with the ALCOA+ principles: attributable, legible, contemporaneous, original and accurate, plus complete, consistent, enduring and available.

Validating those systems is a quality and regulatory responsibility. IT's job is to supply the everyday controls that keep validated systems trustworthy:

• Named user accounts on instruments and lab software, with no shared bench logins where the software supports individual users
• Synchronized clocks across instrument PCs, servers and cloud systems, so audit-trail timestamps line up
• Documented change records for operating system, network and software changes near validated systems
• Backups and archives that preserve original files and their metadata, with restores that are actually tested
• Access reviews that show who could create, change or delete records, and when that changed

Partner and investor questionnaires

Pharma partners, platform customers and investors' diligence teams often send a security questionnaire before they share data or sign. Expect questions on MFA, device management, encryption, logging, incident response, vendor management and backups. If you host partner data or sell a platform or data service, a SOC 2 Type II report may be requested; otherwise a documented control set mapped to NIST CSF or ISO 27001 usually answers the same questions.

California's CCPA, as amended by the CPRA, may also apply depending on your size and the personal information you hold, and clinical-stage teams may handle trial data with its own privacy obligations. We help with readiness and evidence; auditors issue reports, and your counsel interprets the law.

The risks that matter most for biotech teams

Most incidents at research companies don't begin with a sophisticated attack on the science. They begin with ordinary gaps that a fast-growing team never had time to close.

Ransomware completes the list. Research data on a single network share without an immutable copy can be encrypted along with everything else, and rebuilding instrument PCs without saved configurations can take far longer than restoring files.

What good biotech IT looks like

Score yourself row by row. Most growing companies sit in the first column for some areas and the last for others; the aim is to close the gaps a partner's questionnaire or an attacker would find first.

How Alpiba supports biotech and life sciences teams

Our biotech IT services in San Diego can run your IT end to end, or work alongside a first IT hire who needs security depth and after-hours cover. Either way, the work maps to the problems above.

• Segmented lab networks. Network and server consulting designs instrument segments, firewall rules and a controlled data path from bench to storage, with diagrams your quality team can reference.
• Identity and access. Zero-trust identity security puts MFA, conditional access and least-privilege roles on every account, including consultants and partner guests, and removes access the day someone leaves.
• Monitoring around the clock. Our human-staffed 24/7 SOC watches laptops, servers, sign-ins, email and cloud apps, responds in under 15 minutes on average and opens a ransomware containment playbook within the first hour.
• Research data recovery. Immutable off-site backups protect research data, notebook exports and instrument configurations, with documented RTO and RPO targets and restore drills every quarter.
• Questionnaires and audits. Compliance readiness maps your controls to whatever your partners ask for, whether that is SOC 2 Type II readiness, ISO 27001 controls alignment or a NIST CSF mapping, and keeps evidence current between requests. That describes your readiness; it is not a certification of Alpiba.
• Planning for growth. IT strategy and vCIO reviews each quarter connect the IT budget to hiring plans, new lab space and partner deadlines.

Every engagement runs through the same four stages: we learn the lab and its systems, design the changes, implement them in short windows scheduled around experiments, then protect and tune the environment with patching, monitoring and quarterly reviews. If something breaks mid-run, the person who picks up the phone is a senior engineer, not a ticket queue.

Technology choices for a growing lab

Patch or isolate

Patch what you can, isolate what you can't, and write down which is which. Office laptops and servers get updates on a regular schedule. Instrument PCs frozen by vendor support or validation get their own network segment, no internet access unless the vendor's support model needs it, application allow-listing where the vendor permits it and monitoring at the segment boundary.

• Keep an inventory of every instrument PC: operating system, software version, vendor support status, owner and the data it produces.
• Save configurations, methods and license files after each approved change, so a failed PC can be rebuilt to its validated state.
• Give vendors one approved, time-limited and logged way in, instead of their own tools or a modem in the back of the instrument.

Local storage, cloud or both

Large instrument output usually lands on fast local storage near the lab, then moves to cloud storage for analysis, sharing and retention. The trade-off is speed and cost against resilience and access, and most labs need both. What matters is that the path is designed: the instrument writes locally, an automated job copies files to a staging share on the instrument segment, and only that share sends data onward, with originals left unaltered and every transfer logged.

One identity for every research app

Run Microsoft 365 or Google Workspace as the backbone, with one shared site or shared drive per program and per partner rather than personal folders. Connect your electronic lab notebook (ELN), laboratory information management system (LIMS) and other research apps through single sign-on, so MFA and offboarding apply to them automatically.

Alert first, then block

Data loss prevention rules can flag sensitive files leaving the company, but switching straight to blocking frustrates scientists who share legitimately with collaborators. Start in alert-only mode, learn the real sharing patterns for a few weeks, then block the flows that should never happen.

Facilities and power

Keep freezer and incubator alarms, sensors and building systems on their own segment, and put the network gear that carries those alarms on battery backup. Plan for outages, including the Public Safety Power Shutoffs SDG&E can call when wildfire risk is high: decide which instruments shut down gracefully, which stay up and who gets alerted.

A 90-day plan for a growing biotech

If you're moving from founder-managed IT to something a partner would sign off on, this order works. It front-loads the controls that reduce risk fastest and lets evidence build up as you go.

1. Days 1–30: see everything, secure identity

   Inventory people, devices, instruments, cloud apps and where research data lives. Enforce MFA on email and cloud apps, retire shared accounts where the software allows, deploy managed EDR on every laptop and server that can run it and confirm research data has an off-site copy.

2. Days 31–60: separate the lab

   Move instrument PCs and facility devices onto their own segments, replace USB transfers with a controlled data path and put vendor remote access behind approved, logged sessions. Restructure shared storage by program and partner, and clean up stale guest access.

3. Days 61–90: prove it works

   Run a restore drill that includes rebuilding one instrument PC from its saved configuration. Map controls to the framework your partners use, collect evidence, write short policies that match what you actually do and schedule quarterly access reviews.

Close each phase with a one-page summary of what changed and what comes next. Leadership sees progress, your quality team sees the change history, and the summaries become useful evidence later.

How to evaluate an IT partner for your lab

Most providers can set up laptops and email. Fewer understand why you can't simply patch the mass spectrometer's PC, or what a partner's security team will ask next quarter. When you compare biotech IT services in San Diego, these questions separate the two:

1. How would you protect an instrument PC that can't be updated without losing vendor support?
2. How do you coordinate changes near validated systems with our quality team?
3. If an alert fires at 3am on a Sunday, who looks at it, and how quickly?
4. How do you control and log instrument vendor remote access?
5. How often do you test restores, and how do you handle very large research data sets?
6. Which frameworks can you map our controls to, and who keeps the evidence between questionnaires?
7. Do you provide on-site support in Torrey Pines and Sorrento Valley, or remote only?

Red flags

• A plan to push the same updates to every PC in the building, instruments included.
• A single flat network proposed for a new lab because it is simpler to manage.
• No answer for how changes near validated systems will be recorded.
• Backups described in terms of software features, with no restore test dates.

To see how your lab and data path measure up, book a free 30-minute assessment. We'll talk through instruments, identity and research data with you and point out the quick wins, with no obligation.